Comparable stake leader
Injective Foundation
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001938109.
Comparable stake leader
Injective Foundation
Disclosed value leader
Injective Foundation
Comparable rows
10/17
Latest evidence
31 Mar 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
10 of 17 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Injective Foundation |
13D/G
3/4/5
10%+ Owner
|
37%
|
$26,346,155
9,615,385 shares
|
$0 | 30 Dec 2025 |
| Kendall Leo Marin |
3/4/5
13D/G
COO, Director, 10%+ Owner · Marin Kendall Leo
|
10%
from 13D/G
|
$238,209
2,414,736 shares
mixed-class rows
|
— | 16 Jul 2025 |
| Anthony Georgiades |
3/4/5
Director
|
5.1%
|
$881,578
1,315,789 shares
|
— | 06 Jan 2026 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0.11%
|
$17,562
27,428 shares
|
— | 31 Mar 2026 |
| XTX Topco Ltd |
13F
Company
|
0.09%
|
$15,356
23,983 shares
|
— | 31 Mar 2026 |
| Steward Partners Investment Advisory, LLC |
13F
Company
|
0.05%
|
$8,089
12,633 shares
|
— | 31 Mar 2026 |
| Ground Swell Capital, LLC |
13F
Company
|
0.04%
|
$7,209
11,259 shares
|
— | 31 Mar 2026 |
| UBS Group AG |
13F
Company
|
0.02%
|
$2,890
4,516 shares
|
— | 31 Mar 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Aug 2025.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-10 of 10 reporting-owner rows connected to Pineapple Financial Inc.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Anthony Georgiades | Director | $881,578 | Mixed | 06 Jan 2026 | ||
| Charles Andrew Green | Director | $671,815 | Mixed | 16 Jul 2025 | ||
| Christa Lillian Mitchell | CSO, Director | $285,330 | Filing P/S | 01 Aug 2024 | ||
| Kendall Leo Marin | COO, Director, 10%+ Owner | $238,209 | Market | 16 Jul 2025 | ||
| Tasis Anastasios Giannoukakis | Director | $48,000 | Filing P/S | 16 Jul 2025 | ||
| Nima Besharat | Director | $24,857 | Mixed | 12 Oct 2023 | ||
| Shubha-Jeet Dasgupta | CEO, Director, 10%+ Owner | $2,400 | Filing P/S | 16 Jul 2025 | ||
| Habib Syed Sarfraz | Cfo | Mixed | 16 Jul 2025 | |||
| Paul Robert Maurice Baron | Director | Mixed | 16 Jul 2025 | |||
| Injective Foundation | 10%+ Owner | Mixed | 30 Dec 2025 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Anthony Georgiades | PAPL | Common Shares | 0 | 1,315,789 | 06 Jan 2026 | See footnote 1 | ||||
| Injective Foundation | PAPL | Common Shares | 0 | 9,615,385 | 30 Dec 2025 | Direct |